Ana Ruigómez

6.0k total citations · 1 hit paper
97 papers, 4.4k citations indexed

About

Ana Ruigómez is a scholar working on Gastroenterology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ana Ruigómez has authored 97 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Gastroenterology, 37 papers in Surgery and 27 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ana Ruigómez's work include Gastroesophageal reflux and treatments (30 papers), Helicobacter pylori-related gastroenterology studies (25 papers) and Eosinophilic Esophagitis (18 papers). Ana Ruigómez is often cited by papers focused on Gastroesophageal reflux and treatments (30 papers), Helicobacter pylori-related gastroenterology studies (25 papers) and Eosinophilic Esophagitis (18 papers). Ana Ruigómez collaborates with scholars based in Spain, Sweden and United States. Ana Ruigómez's co-authors include Luis A. Garcı́a Rodrı́guez, Saga Johansson, Mari‐Ann Wallander, L.A. García Rodríguez, Julián Panés, Hershel Jick, Elisa Martín‐Merino, Stefan Johansson, Raymond G. Schlienger and Susan S. Jick and has published in prestigious journals such as Gastroenterology, PLoS ONE and American Journal of Epidemiology.

In The Last Decade

Ana Ruigómez

96 papers receiving 4.2k citations

Hit Papers

Validity of the General Practice Research Database 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Validity of the General Practice Research Database
    2003 516 citations Luis A. Garcı́a Rodrı́guez, Ana Ruigómez et al. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy profile →

Peers

Ana Ruigómez
Saga Johansson Sweden
Daniel W. Byrne United States
Dan L. Dumitraşcu Romania
A. P. S. Hungin United Kingdom
Virginia Pate United States
Esther W. Chan Hong Kong
Suzanne F. Cook United States
Laura E. Targownik Canada
Joshua J. Ofman United States
Ross Dierkhising United States
Saga Johansson Sweden
Ana Ruigómez
Citations per year, relative to Ana Ruigómez Ana Ruigómez (= 1×) peers Saga Johansson

Countries citing papers authored by Ana Ruigómez

Since Specialization
Citations

This map shows the geographic impact of Ana Ruigómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Ruigómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Ruigómez more than expected).

Fields of papers citing papers by Ana Ruigómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Ruigómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Ruigómez. The network helps show where Ana Ruigómez may publish in the future.

Co-authorship network of co-authors of Ana Ruigómez

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Ruigómez. A scholar is included among the top collaborators of Ana Ruigómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Ruigómez. Ana Ruigómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruigómez, Ana, Tania Schink, Ron M. C. Herings, et al.. (2024). Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries. PLoS ONE. 19(3). e0298596–e0298596. 1 indexed citations
2.
Rodrı́guez, Luis A. Garcı́a, Mari‐Ann Wallander, Leif Friberg, et al.. (2020). Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice. Expert Opinion on Drug Safety. 19(11). 1513–1520. 4 indexed citations
3.
Rodrı́guez, Luis A. Garcı́a, Mar Martín‐Pérez, Pareen Vora, et al.. (2019). Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK. BMJ Open. 9(9). e031341–e031341. 27 indexed citations
4.
Brauer, Ruth, Ian Douglas, Luis A. Garcı́a Rodrı́guez, et al.. (2016). Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case–control studies using two primary care databases in Europe. Pharmacoepidemiology and Drug Safety. 25(S1). 29–38. 13 indexed citations
5.
Martín‐Pérez, Mar, Ana Ruigómez, Alexander Michel, & Luis A. Garcı́a Rodrı́guez. (2016). Incidence and risk factors for atrial fibrillation in patients with newly diagnosed heart failure. Journal of Cardiovascular Medicine. 17(8). 608–615. 9 indexed citations
6.
Michel, Alexander, Mar Martín‐Pérez, Ana Ruigómez, & Luis A. Garcı́a Rodrı́guez. (2015). Risk Factors for Hyperkalaemia in a Cohort of Patients with Newly Diagnosed Heart Failure: A Nested Case–Control Study in UK General Practice. European Journal of Heart Failure. 17(2). 205–213. 49 indexed citations
7.
Brauer, Ruth, Ana Ruigómez, Olaf H. Klungel, et al.. (2015). The risk of acute liver injury among users of antibiotic medications: a comparison of case‐only studies.. Pharmacoepidemiology and Drug Safety. 25(S1). 39–46. 9 indexed citations
8.
Vassilev, Zdravko P., Ana Ruigómez, Montse Soriano‐Gabarró, & L. A. Garcia Rodriguez. (2015). Diabetes, Cardiovascular Morbidity, and Risk of Age-Related Macular Degeneration in a Primary Care Population. Investigative Ophthalmology & Visual Science. 56(3). 1585–1592. 45 indexed citations
9.
Ruigómez, Ana, A. P. S. Hungin, Per Lundborg, et al.. (2011). Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease. European Journal of Gastroenterology & Hepatology. 23(3). 232–237. 5 indexed citations
10.
Ruigómez, Ana, Mari‐Ann Wallander, Saga Johansson, & Luis A. Garcı́a Rodrı́guez. (2008). Irritable Bowel Syndrome and Gastroesophageal Reflux Disease in Primary Care: Is There a Link?. Digestive Diseases and Sciences. 54(5). 1079–1086. 15 indexed citations
11.
Rodrı́guez, Luis A. Garcı́a, Ana Ruigómez, Elisa Martín‐Merino, Saga Johansson, & Mari‐Ann Wallander. (2008). Relationship Between Gastroesophageal Reflux Disease and COPD in UK Primary Care. CHEST Journal. 134(6). 1223–1230. 48 indexed citations
12.
Wallander, Mari‐Ann, et al.. (2007). Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Family Practice. 24(5). 403–411. 48 indexed citations
13.
Ruigómez, Ana, Luis A. Garcı́a Rodrı́guez, Mari‐Ann Wallander, Saga Johansson, & Roger Jones. (2006). Chest pain in general practice: incidence, comorbidity and mortality. Family Practice. 23(2). 167–174. 111 indexed citations
14.
Hollowell, Jennifer, Ana Ruigómez, Saga Johansson, Mari‐Ann Wallander, & Luis A. García‐Rodríguez. (2003). The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom.. PubMed. 53(489). 312–4. 36 indexed citations
15.
Ruigómez, Ana, Saga Johansson, Mari‐Ann Wallander, & Luis A. Garcı́a Rodrı́guez. (2001). Gender and drug treatment as determinants of mortality in a cohort of heart failure patients. European Journal of Epidemiology. 17(4). 329–335. 4 indexed citations
16.
Ruigómez, Ana & Luis A. Garcı́a Rodrı́guez. (1998). Presence of diabetes related complication at the time of NIDDM diagnosis: An important prognostic factor. European Journal of Epidemiology. 14(5). 439–445. 14 indexed citations
17.
Rodrı́guez, Luis A. Garcı́a, Ana Ruigómez, & Hershel Jick. (1997). A Review of Epidemiologic Research on Drug‐Induced Acute Liver Injury Using the General Practice Research Data Base in the United Kingdom. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(4). 721–728. 54 indexed citations
18.
Alonso, Jordi, Francesc Orfila, Ana Ruigómez, Montse Ferrer, & Josep M. Antó. (1997). Unmet health care needs and mortality among Spanish elderly.. American Journal of Public Health. 87(3). 365–370. 77 indexed citations
19.
Ruigómez, Ana & Jordi Alonso. (1996). Validez de la medida de la capacidad funcional a través de las actividades básicas de la vida diaria en la población anciana. 6(4). 215–223. 6 indexed citations
20.
Espallargues, Mireia, Juli Alonso, Ana Ruigómez, & Antó Jm. (1996). [Osteoarticular disorders in the elderly: an approach to their population impact].. PubMed. 106(16). 601–6. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saga Johansson Breakdown of academic impact, for papers by Daniel W. Byrne Breakdown of academic impact, for papers by Dan L. Dumitraşcu Breakdown of academic impact, for papers by A. P. S. Hungin Breakdown of academic impact, for papers by Virginia Pate Breakdown of academic impact, for papers by Esther W. Chan Breakdown of academic impact, for papers by Suzanne F. Cook Breakdown of academic impact, for papers by Laura E. Targownik Breakdown of academic impact, for papers by Joshua J. Ofman Breakdown of academic impact, for papers by Ross Dierkhising
Rankless by CCL
2026